Adenomyosis in mice resulting from mechanically or thermally induced endometrial–myometrial interface disruption and its possible prevention

Meihua Hao,Xishi Liu,Sun-Wei Guo
DOI: https://doi.org/10.1016/j.rbmo.2020.07.023
IF: 4.567
2020-11-01
Reproductive BioMedicine Online
Abstract:<p><strong>RESEARCH QUESTION:</strong> Do uterine procedures potentially disrupting the endometrial-myometrial interface (EMI) induce adenomyosis?</p><p><strong>DESIGN:</strong> We conducted 6 prospective, randomized and controlled experimentations involving a total of 106 female Balb/C and 12 C57/BL6 mice. We evaluated the incidence of adenomyosis in two strains of mouse with mechanically induced EMI disruption (EMID) and in mouse with thermally induced EMID through electrocoagulation of different intensity. Finally, we evaluated the incidence in mice that received perioperative administration of aprepitant (an NK1R inhibitor), or propranolol (a β-blocker), or just vehicle. Bodyweight, hotplate latency and the depth of myometrial infiltration were evaluated. Histology, immunohistochemistry and histochemistry analyses were also performed.</p><p><strong>RESULTS:</strong> Mechanical injury to the EMI caused EMID. Adenomyosis was successfully developed in the majority of mice in the EMID group (83.3% and 100%) 3 months after mechanically induced EMID but none in the control group (p&lt;0.05). For thermally induced EMID, adenomyosis was found in 30% of the EMID mice 10 weeks after, but the incidence increased to 66.7% if the extent of EMID damage was increased. In mice with perioperative administration of aprepitant or propranolol, the incidence of adenomyosis was reduced from 100% to 58.3% (p&lt;0.05).</p><p><strong>CONCLUSION:</strong> Our study provides the first piece of experimental evidence that EMID resulting from iatrogenic uterine procedures can substantially increase the risk of developing adenomyosis, with the risk in proportional to the severity of disruption. More intriguingly, perioperative administration of an NK1R antagonist or a β-blocker can significantly reduce the risk of developing adenomyosis.</p>
obstetrics & gynecology,reproductive biology
What problem does this paper attempt to address?